Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 58

1.

Quantitative proteomics profiling of primary lung adenocarcinoma tumors reveals functional perturbations in tumor metabolism.

Pernemalm M, De Petris L, Branca RM, Forshed J, Kanter L, Soria JC, Girard P, Validire P, Pawitan Y, van den Oord J, Lazar V, Påhlman S, Lewensohn R, Lehtiö J.

J Proteome Res. 2013 Sep 6;12(9):3934-43. doi: 10.1021/pr4002096. Epub 2013 Aug 13.

2.

Differential proteomic profiling of chordomas and analysis of prognostic factors.

Zhou H, Chen CB, Lan J, Liu C, Liu XG, Jiang L, Wei F, Ma QJ, Dang GT, Liu ZJ.

J Surg Oncol. 2010 Dec 1;102(7):720-7. doi: 10.1002/jso.21674.

PMID:
20721957
3.

Identification of proteins expressed differently among surgically resected stage I lung adenocarcinomas.

Ha ES, Choi S, In KH, Lee SH, Lee EJ, Lee SY, Kim JH, Shin C, Shim JJ, Kang KH, Phark S, Sul D.

Clin Biochem. 2013 Mar;46(4-5):369-77. doi: 10.1016/j.clinbiochem.2012.11.014. Epub 2012 Nov 29.

PMID:
23200884
4.

Glycolysis module activated by hypoxia-inducible factor 1alpha is related to the aggressive phenotype of hepatocellular carcinoma.

Hamaguchi T, Iizuka N, Tsunedomi R, Hamamoto Y, Miyamoto T, Iida M, Tokuhisa Y, Sakamoto K, Takashima M, Tamesa T, Oka M.

Int J Oncol. 2008 Oct;33(4):725-31.

PMID:
18813785
5.

Proteomic features of potential tumor suppressor NESG1 in nasopharyngeal carcinoma.

Liu Z, Chen C, Yang H, Zhang Y, Long J, Long X, Fang W.

Proteomics. 2012 Nov;12(22):3416-25. doi: 10.1002/pmic.201200146. Epub 2012 Oct 19.

PMID:
22997098
6.

Relation of hypoxia inducible factor 1 alpha and 2 alpha in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survival.

Giatromanolaki A, Koukourakis MI, Sivridis E, Turley H, Talks K, Pezzella F, Gatter KC, Harris AL.

Br J Cancer. 2001 Sep 14;85(6):881-90.

7.

Combination of protein coding and noncoding gene expression as a robust prognostic classifier in stage I lung adenocarcinoma.

Akagi I, Okayama H, Schetter AJ, Robles AI, Kohno T, Bowman ED, Kazandjian D, Welsh JA, Oue N, Saito M, Miyashita M, Uchida E, Takizawa T, Takenoshita S, Skaug V, Mollerup S, Haugen A, Yokota J, Harris CC.

Cancer Res. 2013 Jul 1;73(13):3821-32. doi: 10.1158/0008-5472.CAN-13-0031. Epub 2013 May 2.

8.

Proteomic analysis of secreted proteins of non-small cell lung cancer.

Huang LJ, Chen SX, Luo WJ, Jiang HH, Zhang PF, Yi H.

Ai Zheng. 2006 Nov;25(11):1361-7.

PMID:
17094902
9.

Differential proteomic analysis of noncardia gastric cancer from individuals of northern Brazil.

Leal MF, Chung J, Calcagno DQ, Assumpção PP, Demachki S, da Silva ID, Chammas R, Burbano RR, de Arruda Cardoso Smith M.

PLoS One. 2012;7(7):e42255. doi: 10.1371/journal.pone.0042255. Epub 2012 Jul 30.

10.

ENO1, a potential prognostic head and neck cancer marker, promotes transformation partly via chemokine CCL20 induction.

Tsai ST, Chien IH, Shen WH, Kuo YZ, Jin YT, Wong TY, Hsiao JR, Wang HP, Shih NY, Wu LW.

Eur J Cancer. 2010 Jun;46(9):1712-23. doi: 10.1016/j.ejca.2010.03.018.

PMID:
20435467
11.

Increased expression of hypoxia-inducible factor 1alpha in type I and type II endometrial carcinomas.

Pansare V, Munkarah AR, Schimp V, Haitham Arabi M, Saed GM, Morris RT, Ali-Fehmi R.

Mod Pathol. 2007 Jan;20(1):35-43. Epub 2006 Nov 10.

12.

Increased expression of enolase alpha in human breast cancer confers tamoxifen resistance in human breast cancer cells.

Tu SH, Chang CC, Chen CS, Tam KW, Wang YJ, Lee CH, Lin HW, Cheng TC, Huang CS, Chu JS, Shih NY, Chen LC, Leu SJ, Ho YS, Wu CH.

Breast Cancer Res Treat. 2010 Jun;121(3):539-53. doi: 10.1007/s10549-009-0492-0. Epub 2009 Aug 5.

PMID:
19655245
13.

Napsin A is an independent prognostic factor in surgically resected adenocarcinoma of the lung.

Lee JG, Kim S, Shim HS.

Lung Cancer. 2012 Jul;77(1):156-61. doi: 10.1016/j.lungcan.2012.02.013. Epub 2012 Mar 13.

PMID:
22418245
14.

Expression of hypoxia-inducible factor-1 alpha and its prognostic significance in small-sized adenocarcinomas of the lung.

Enatsu S, Iwasaki A, Shirakusa T, Hamasaki M, Nabeshima K, Iwasaki H, Kuroki M, Kuroki M.

Eur J Cardiothorac Surg. 2006 Jun;29(6):891-5. Epub 2006 May 3.

PMID:
16675263
15.

Quantitative proteome analysis reveals annexin A3 as a novel biomarker in lung adenocarcinoma.

Liu YF, Xiao ZQ, Li MX, Li MY, Zhang PF, Li C, Li F, Chen YH, Yi H, Yao HX, Chen ZC.

J Pathol. 2009 Jan;217(1):54-64. doi: 10.1002/path.2429.

PMID:
18798225
16.

Expression of a truncated active form of VDAC1 in lung cancer associates with hypoxic cell survival and correlates with progression to chemotherapy resistance.

Brahimi-Horn MC, Ben-Hail D, Ilie M, Gounon P, Rouleau M, Hofman V, Doyen J, Mari B, Shoshan-Barmatz V, Hofman P, Pouysségur J, Mazure NM.

Cancer Res. 2012 Apr 15;72(8):2140-50. doi: 10.1158/0008-5472.CAN-11-3940. Epub 2012 Mar 2.

17.

Expression of the transient receptor potential channel c3 correlates with a favorable prognosis in patients with adenocarcinoma of the lung.

Saito H, Minamiya Y, Watanabe H, Takahashi N, Ito M, Toda H, Konno H, Mitsui M, Motoyama S, Ogawa J.

Ann Surg Oncol. 2011 Nov;18(12):3377-83. doi: 10.1245/s10434-011-1798-9. Epub 2011 May 21.

PMID:
21603869
18.

Identification of isocitrate dehydrogenase 1 as a potential diagnostic and prognostic biomarker for non-small cell lung cancer by proteomic analysis.

Tan F, Jiang Y, Sun N, Chen Z, Lv Y, Shao K, Li N, Qiu B, Gao Y, Li B, Tan X, Zhou F, Wang Z, Ding D, Wang J, Sun J, Hang J, Shi S, Feng X, He F, He J.

Mol Cell Proteomics. 2012 Feb;11(2):M111.008821. doi: 10.1074/mcp.M111.008821. Epub 2011 Nov 7.

19.

Immunohistochemical study of Skp2 and Jab1, two key molecules in the degradation of P27, in lung adenocarcinoma.

Goto A, Niki T, Moriyama S, Funata N, Moriyama H, Nishimura Y, Tsuchida R, Kato JY, Fukayama M.

Pathol Int. 2004 Sep;54(9):675-81.

PMID:
15363035
20.

Identification of the hypoxia-inducible factor 2α nuclear interactome in melanoma cells reveals master proteins involved in melanoma development.

Steunou AL, Ducoux-Petit M, Lazar I, Monsarrat B, Erard M, Muller C, Clottes E, Burlet-Schiltz O, Nieto L.

Mol Cell Proteomics. 2013 Mar;12(3):736-48. doi: 10.1074/mcp.M112.020727. Epub 2012 Dec 28.

Supplemental Content

Support Center